SPIRIT-Path: International Guidance on the Inclusion of Pathology in Clinical Trial Protocols

Our international group of researchers, led by the National Cancer Research Institute’s (NCRI) Cellular Molecular Pathology Initiative (CMPath), has published guidance in The Lancet Oncology to address the variability in how pathology is planned and... Read more

29 Sep 2021